Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Cindy Delbrook"'
Autor:
Staci Martin, Maryalice Stetler-Stevenson, Sandhya R. Panch, Seth M. Steinberg, Steven L. Highfill, Haris Qureshi, Cindy Delbrook, Haiying Qin, Alina Dulau-Florea, Hao-Wei Wang, Crystal L. Mackall, Jianjian Jin, Constance M. Yuan, Lauren Little, Pamela L. Wolters, David F. Stroncek, Haneen Shalabi, Leah Hoffman, Dalia Salem, Terry J. Fry, Nirali N. Shah, Anusha Ponduri, Minh Tran, Bonnie Yates, Amanda K. Ombrello
Publikováno v:
J Clin Oncol
PURPOSE Patients with B-cell acute lymphoblastic leukemia who experience relapse after or are resistant to CD19-targeted immunotherapies have limited treatment options. Targeting CD22, an alternative B-cell antigen, represents an alternate strategy.
Autor:
Staci Martin, Robbie G. Majzner, Constance M. Yuan, Bonnie Yates, Jack F. Shern, Haneen Shalabi, Haiying Qin, David F. Stroncek, Marianna Sabatino, Terry J. Fry, Boro Dropulic, Cindy Delbrook, Yang Feng, Nirali N. Shah, Thomas J. Fountaine, Rimas J. Orentas, Daniel W. Lee, Crystal L. Mackall, Maryalice Stetler-Stevenson, Sneha Ramakrishna, Pamela L. Wolters, Dimiter S. Dimitrov, Ling Zhang, Sang M. Nguyen
Publikováno v:
Nature Medicine. 24:20-28
Chimeric antigen receptor (CAR) T cells targeting CD19 mediate potent effects in relapsed and/or refractory pre-B cell acute lymphoblastic leukemia (B-ALL), but antigen loss is a frequent cause of resistance to CD19-targeted immunotherapy. CD22 is al
Autor:
Jack F. Shern, Elaine S. Jaffe, Ira Lignugaris Kraft, Haneen Shalabi, Constance M. Yuan, Terry J. Fry, Hao-Wei Wang, Julie D. Zimbelman, Daniel W. Lee, Maryalice Stetler-Stevenson, Roger Giller, Cindy Delbrook, Nirali N. Shah, Bonnie Yates
Diffuse large B-cell lymphoma (DLBCL) is the predominant subtype of Non-Hodgkin lymphoma (NHL) in adolescents and adults. Originating from a B-cell lineage, the neoplastic cells typically express pan-B- cell antigens including CD19, CD20 and CD22.[1]
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca52ca71feff65eb6d3144942af93cda
https://europepmc.org/articles/PMC5927974/
https://europepmc.org/articles/PMC5927974/
Autor:
Robert J. Kreitman, Constance M. Yuan, Kelly Richards, Cindy Delbrook, Alan S. Wayne, Nirali N. Shah, Ira Pastan, Maryalice Stetler Stevenson
Publikováno v:
Pediatric Blood & Cancer. 62:964-969
Background CD22 is a B-lineage differentiation antigen that has emerged as a leading therapeutic target in acute lymphoblastic leukemia (ALL).
Autor:
Bonnie Yates, Terry J. Fry, Hua Zhang, Marianna Sabatino, Kimberly Lemberg, Thomas A. Fleisher, Crystal L. Mackall, Nirali N. Shah, Daniel W. Lee, Cindy Delbrook, Shakuntala Rampertaap, David F. Stroncek
Publikováno v:
Biology of Blood and Marrow Transplantation. 21:S309